MidAmerica Healthcare Venture Forum: Agenda

MidAmerica Healthcare Venture Forum

Agenda

Tuesday, September 30^th
5:00-6:30 p.m.	Welcome Reception

Wednesday, October 1^st
7:30-8:45 a.m.	Breakfast & Networking Reception
8:45-9:00 a.m.	Welcome & Opening Remarks Conference Chairman: Peter Kleinhenz Managing Director CID Capital Host Committee Chair: Carol Frankenstein President BIOSTART
9:00-9:45 a.m.	Conference Keynote Address: The State of the Healthcare Marketplace Robbie Huffines Co-head of Global Healthcare Investment Banking Group J.P. Morgan Chase
9:45-10:45 a.m.	Coast-to-Coast Venture Capital Healthcare Investing: Who’s doing what, where, and why? Some of the most active healthcare VCs from across the country will discuss investment trends and strategies regionally and nationally. What kind of deals are they going after and where are they finding them? What are the perceived advantages/disadvantages of companies based in the Midwest vs. the East & West Coasts? Moderator: Baiju Shah President & CEO BioEnterprise, Inc. Panelists: Sanuj Ravindran, M.D. Principal Radius Ventures Fred M. Schwarzer Managing Partner Charter Life Science David Darst Associate OrbiMed Advisors Anupendra Sharma Investment Partner Siemens Venture Capital
10:45-11:15 a.m.	Networking & Refreshment Break
11:15-12:30 p.m.	Presenting Company Showcase Track 1: Biotechnology & Pharmaceutical Company Showcase Time 11:15-11:25 11:25-11:35 11:35-11:45 11:45-11:55 11:55-12:05 12:05-12:15 12:15-12:25 Company Akebia Therapeutics, Inc. CS-Keys, Inc. RhinoCyte, Inc. ZyStor Therapeutics, Inc. Medtrinia Pharmaceuticals Metabolic Solutions Development Co. Mithridion, Inc. Presenter Joseph Gardner CEO Claire Deselle President & CEO Fred J. Roisen, PhD Co-founder, President & CEO Loren G Peterson President & CEO Thomas A. Collet President & CEO Mark Olesnavage CEO Trevor M. Twose, PhD CEO Track 2: Biotechnology & Pharmaceutical Company Showcase Time 11:15-11:25 11:25-11:35 11:35-11:45 11:45-11:55 11:55-12:05 Company AllTranz, Inc. CDG Therapeutics Immuno Theragnostics Incorporated PDS Biotechnology Corporation MedCara Pharmaceuticals, LLC Presenter Audra Stinchcomb, PhD Founder & CEO David R. Volk CEO Andrew Steen VP, Business Development Frank Bedu-Addo President & CEO Tom Swegle CEO Track 3: Medical Device Company Showcase Time 11:15-11:25 11:25-11:35 11:35-11:45 11:45-11:55 11:55-12:05 12:05-12:15 12:15-12:25 Company SonarMed, Inc. Nephrion, Inc. InformMed Inc. KC BioMediX, Inc. NDI Medical Thermal Therapeutic Systems Nerites Corporation Presenter David B. Wortman Chairman Clint Dederick Chairman & CEO Gary Conkright CEO Michael Litscher CEO & COO Len Cosentino VP Business Development Raymond F. Vennare Co-Founder & CEO Jediah White Director of Business Development
12:30-2:00 p.m.	Luncheon with Keynote Maribeth Rahe President & CEO Fort Washington Investment Advisors, Inc. Sponsored By Healthcare and Private Equity: A Perspective from a National Fun of Funds Investor
2:00-3:00 p.m.	Presenting Company Showcase Track 1: Medical Diagnostic Company Showcase Time 2:00-2:10 2:10-2:20 2:20-2:30 2:30-2:40 2:40-2:50 2:50-3:00 Company Orasi Medical Platypus Technologies, LLP AssureRx, LLC EraGen Biosciences, Inc. Armune BioScience, Inc. Svelte Medical Systems Presenter Shawn Lyndon Founder & CEO Maria Perr Director of Marketing Mark T. Byrne CEO Irene Hrusovsky President & CEO Eli Thomssen President & CEO Mark Pomeranz President Track 2: Medical Device Company Showcase Time 2:00-2:10 2:10-2:20 2:20-2:30 2:30-2:40 Company Imalux Corporation Symbios Medical Products VitalMedix, Inc. CH Mack, Inc. Presenter Bill Sanford Chairman & CEO Herb Senft President Jeffrey M. Williams CEO Chris Boue CEO Track 3: Biotechnology & Pharmaceutical Company Showcase Time 2:00-2:10 2:10-2:20 2:20-2:30 2:30-2:40 2:40-2:50 2:50-3:00 Company VasoGenix Pharmaceuticals, Inc. AcelleRX Therapeutics ImmuneWorks, Inc. Cellectar, Inc. ApoImmune, Inc. arGentis Pharmaceuticals Presenter G. Lee Southard, PhD Chairman & CEO Rahul Aras President & CEO Wade Lange President & CEO William R. Clarke, MD President & CEO Steven Downey President & CEO Buddy Lyons CFO
3:00-3:30 p.m.	Networking & Refreshment Break
3:30-4:30 p.m.	The Winner’s Circle: What it takes to make it to the finish line? This session will highlight some of the prominent M&A and IPO transactions from across the Midwest over the past year. What made these deals significant and how did they come together? Moderators: Mina Patel Sooch, M.B.A. Founder and Managing Director Apjohn Ventures Kathy Tune Associate Thomas McNerney Partners Award Recipients: Bonnie Baskin Former CEO & Founder Apptec USA Bob Palay Former Chairman & Co-Founder NimbleGen, Inc. John Neis Co-Founder & Managing Director Venture Investors LLC Board Director, Tomo Therapy John McIlwraith Managing Director Blue Chip Venture Company Board Member, Renal Solutions Honorable Recognition: Esperion Therapeutics, Inc. Nanosphere, Inc.
4:30-5:30 p.m.	Navigating the Current Fundraising Landscape In this session, we will gain insights and perspectives on fundraising issues and techniques from a major consulting group, two well-known fund of funds managers and a branded VC with a successful IR program: How can regional funds better position themselves, given an overall LP bias for East-West Coast VCs? What are the elements of a winning presentation? Fundraising “Do’s and Don’ts”, beginning with initial contact to follow up Between fundraising cycles, how do fund managers build their brand and maintain LP visibility? Moderator: Bonnie R. Plunkett Managing Director Alternative Investment Source LLC Panelists: Avinash N. Amin, MD Senior Vice President Summit Strategies Group Mark T. Regal Director, Customized Fund Investment Group Credit Suisse Kate Sidebottom Simpson Vice President Parish Capital Spencer L. Timm Investor Relations Partner Morgenthaler Ventures
5:30-6:30 p.m.	Cocktail Reception

Thursday, October 2^nd
8:00-9:00 a.m.	Breakfast & Networking Reception
9:00-10:00 a.m.	Corporate Strategic Investing & Acquisitions: What are they looking for? Business development executives from medical device, diagnostic, pharmaceutical and biotech companies will discuss: What types of technologies and healthcare sectors are they focused on for investments, alliances, or acquisitions? At what stage in the company’s development will they evaluate the company for investment or acquisition? How would they decide to invest in a venture round versus acquire the company? Moderator: Jan Garfinkle Managing Director Arboretum Ventures Panelists: Matt Alves VP of Program Development Stryker Instruments Kevin Driscoll Director, Global New Business & Technology Development Procter & Gamble Pharmaceuticals Dan Sheehan Vice President Covidien Ventures Gary Noonan Senior Director Corporate Business Development Eli Lilly
10:00-11:00 a.m.	Presidential Candidates Healthcare Policy Debate Moderator: John Sheils Senior Vice President The Lewin Group Presidential Candidate Representatives: Michael C. Burgess, M.D. US Congressman State of Texas Kevin Grumbach, M.D. Professor and Chair of the Department of Family and Community Medicine University of California, San Francisco Chief of Family and Community Medicine San Francisco General Hospital
11:00-11:30 a.m.	Networking & Reception Break
11:30-12:30 a.m.	Presenting Company Showcase Track 1: Biotech Company Showcase Time 11:30-11:40 11:40-11:50 11:50-12:00 12:00-12:10 12:10-12:20 Company Chromatin Inc. Bexion Pharmaceuticals, LLC Venomix, Inc. Ausio Pharmaceuticals Esclapeus Biopharmaceuticals Presenter Daphne Preuss President & CEO Ray Takigiku, PhD President & CEO John McIntyre President & CEO Richard L. Jackson President & CEO Dr. Khew-Voon Chin Founder & Interm CEO Track 2: MedTech Company Showcase Time 11:30-11:40 11:40-11:50 11:50-12:00 12:00-12:10 12:10-12:20 12:20-12:30 Company OrthoData, Inc. Accord Biomaterials, Inc. AxioMed Spine Corporation NeuWave Medical, Inc. Sword Diagnostics TissueGen Presenter Tim Prell President & CEO Kris Aalto President Patrick McBrayer President & CEO Laura G. King President & CEO David Dingott President Keith W. Brown President & CEO
12:30-1:45 p.m.	Luncheon with Closing Keynote Joe Morgan, C.F.A. Chief Investment Officer and Head of Portfolio Management SVB Asset Management The Economic Environment: How is the government working with a conclusion of our outlook for recovery into the foreseeable future? What are their efforts to prop up the financial system?
1:45 p.m.	Program Adjourns

AGENDA IS TENTATIVE AND IS SUBJECT TO CHANGE WITHOUT NOTICE

Copyright © 2008 IBF Conferences – International Business Forum. All Rights Reserved. Internet marketing by AmazeMind.com